Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M996Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M12.0EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)29.4Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.1PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M6,950,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IHE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Atkinson, Richard Collier10% Security Holder 2016-05-06Buy169,000$0.08178950view
Reeson, DouglasDirector, Senior Officer 2016-05-06Buy100,000$0.03477366.67view
Crossett, Paul Everett10% Security Holder 2016-05-06Buy61,000$155-7.59view
Bal, Jatinder SinghIssuer 2016-05-06Sell20,000$0.06238633.33view
Bowerman, GordonDirector 2016-05-05Buy5,000$1.0713286.92view
Yamini, BahmanDirector, Senior Officer 2016-05-03Buy5,000$0.2362178.26view
Buskard, James LivingstoneSenior Officer 2016-05-02Sell50,000$0.5525943.64view
Bal, Jatinder SinghDirector 2016-05-02Sell125,000$0.1143140view
Bal, Jatinder SinghIssuer 2016-05-02Sell30,000$0.05286380view
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.997097.99view

Quarterly/Annual Reports about IHE:

    News about IHE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Mudslinging Over Valeant Pharmaceuticals May 07 2016
    Pharma ETFs Outlook -- Drug Pricing Issues Remain in Focus May 04 2016
    Finding Pharmaceuticals ETFs With Rebound Potential May 04 2016
    The Last Week of April Wasn’t Good for Biotechnology Stocks May 02 2016
    Fertilizer Impact: Natural Gas Prices Rise Yet Again for Week Ending April 22 Apr 28 2016
    A Segment-by-Segment Breakdown of JNJ’s 1Q16 Earnings Apr 25 2016
    5 Best Performing Bull Run Equity ETFs Mar 09 2016
    Drug Patent Expirations: $190 Billion Is Up for Grabs Mar 03 2016
    Other Industries That Depend on Specialty Chemicals—and Why Mar 02 2016
    Look Beyond Pharma to Opportunities in Generics! Mar 01 2016
    What Does 2016 Hold in Store for Pharma ETFs Jan 04 2016
    How Will Johnson & Johnson’s Pharmaceutical Segment Do in 4Q15? Dec 31 2015
    IYZ Sees $57.2 Million in Fund Outflows in Trailing 12 Months Dec 29 2015
    IYZ Sees $59.3 Million in Fund Inflows in Trailing 12 Months Dec 17 2015
    The iShares US Medical Devices ETF (IHI) Has Put Nothing under the Tree in December—Yet Dec 16 2015
    IYW Sees $61.7 Billion in Fund Inflows in Trailing 1 Month Dec 11 2015
    Pfizer in Talks to Buy Allergan: Prescribed ETFs Nov 19 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)